Answer:- A person with deficiency of iron,calacium or zinc is most probable to absorb cadmium(Cd) in intestines.It affects the upregulation of transport pathways in proximal S1 segment of the kidney tubule as here Cd gets deposited(about 30%).Metallotheonine bound Cd gets degraded into endosomes and lysosomes releasing free Cd into the cytosol where it generate reactive oxygen species and activate cell death pathways.It impairs reabsorption of low molecular weight proteins such as retinol binding protein(Tubular proteinuria).Heavy Cd toxicity can cause fancoi syndrome and may leads to renal failure.It causes defects in protein,glucose,phosphate reabsorption due to oxidative damage to transport proteins and mitochondria.It also affects vit.D metabolism in kidney which further impact on bones(osteomalacia/osteoporosis).
Most of Cd in body bounds to a metal binding protein called Metallotheonie.It plays an importanat role in metabolism and toxcity of Cd.Human adult renal metallothionein has natural content of Cd which induces the resynthesis of this protein upon its catabolism.Metallothionein causes homeostasis of essential metals like copper,zinc,protect against cytotoxicity of Cd and other toxic metals,scavenges free radicals generated in oxidative stress.Induction of Metallothionein decreases Cd toxicity and protect against CdCl2 induced hepatotoxicity but it doesn't protect against acute Cd-metallothionein induced nephrotoxicity.
Discuss Cd toxicity in the kidney and the role of metallothionein in mitigating (or not this...
Explain the role that public health leaders can play in mitigating adverse impacts to the public health workforce. Discuss how advocacy by public health leaders can influence the public health workforce. Provide examples to support your reasoning.
Why is there an increased risk of drug toxicity in the later stages of kidney failure?
Why is there an increased risk of drug toxicity in the later stages of kidney failure?
Discuss different policies of currency valuation and strategies for mitigating exchange risk.
discuss the stages of chronic kidney disease. What are causes and symptoms associated with chronic kidney disease? Additionally, please identify methods of monitoring and treating patients with chronic kidney disease. please provide references
infants are at risk for drug toxicity due to which of the following? (Select all that apply) Infants are at risk for drug toxicity due to which of the following? (Select all that apply.) Decreased liver enzymes Reduced kidney perfusion Increased stomach acid Reduced percentage of body water Reduced liver perfusion PREVIOUS
Plasma K+ levels are critical, and the kidney plays a major role in maintaining the level at around 5mM (the extracellular concentration). What would happen to cell membrane potential if: a) the kidney allowed too much K+ loss in the urine? b) too much K+ was lost and a doctor replacing the K+ in an infusion drip in hospital gave too much K+ over a short period of time?
1. Discuss the role of nutrition in bone health and in the prevention of osteoporosis and osteomalacia. 2. Describe the major functions of the nutrients involved in bone health. 3. Describe the major functions of the nutrients involved in body defense systems. 4. List the major food sources for the nutrients involved in bone health and in body defense systems. 5. Describe the metabolism of the vitamins and minerals involved in bone health and body defense. 6. Describe the deficiency...
Discuss a kidney disorder. 2. What is the course of treatment for this disorder? 3. What is the diet for this disorder? 4. Which lab values and/or electrolytes should be monitored in kidney disorders? 5. What is polysterene sulfonate?
1. Discuss a kidney disorder. 2. What is the course of treatment for this disorder? 3. What is the diet for this disorder? 4. Which lab values and/or electrolytes should be monitored in kidney disorders? 5. What is polysterene sulfonate?